Changing referral characteristics of patients with autosomal dominant polycystic kidney disease

American Journal of Medicine

Volumn 126, Issue 9, 2013, Pages 832.e7-832.e11

  Helal, Imed ^a   McFann, Kim ^a   Reed, Berenice ^a   Yan, Xiang Dong ^a   Schrier, Robert W ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Blood pressure; Chronic kidney disease; Renal progression

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DIURETIC THERAPY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PATIENT REFERRAL; PRIORITY JOURNAL; PROTEINURIA; RETROSPECTIVE STUDY; SYSTOLIC BLOOD PRESSURE; TIME;

EID: 84883233110     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2012.12.018     Document Type: Article

References (16)

1. C. Iglesias, V. Torres, K. Offord, K. Holley, C. Beard, and L. Kurland Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980 Am J Kidney Dis 2 1983 630 639
2. T. Ecder, G.M. Fick-Brosnahan, and R.W. Schrier Polycystic kidney disease R.W. Schrier, Diseases of the Kidney and Urinary Tract 8th ed. 2007 Lippincott Williams & Wilkins Philadelphia, PA 502 539
3. US Renal Data System USRDS 2011 Annual Data Report 2011 USRDS Coordinating Center Minneapolis, MN
4. PKD Foundation Polycystic Kidney Disease: The Most Common Life-Threatening Genetic Disease 2000 Polycystic Kidney Research Foundation Kansas City, KS
5. V.E. Torres, P. Harri, and V. Pirson Autosomal dominant polycystic kidney disease Lancet 369 2007 1287 1301
6. R.W. Schrier Hypertension and autosomal dominant polycystic kidney disease Am J Kidney Dis 57 2011 811 813
7. A.B. Chapman, A. Johnson, P.A. Gabow, and R.W. Schrier The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease N Engl J Med 323 1990 1091 1096
8. M. Loghman-Adham, C.E. Soto, T. Inagami, and L. Cassis The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease Am J Physiol Renal Physiol 287 2004 F775 F788
9. Y. Pei, J. Obaji, and A. Dupuis Unified criteria for ultrasonographic diagnosis of ADPKD J Am Soc Nephrol 20 2009 205 212
10. L.A. Inker, J. Bickfeldt, and Levey As Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values Am J Kidney Dis 58 2011 682 684
11. M. Taylor, A.M. Johnson, M. Tison, P. Fain, and R.W. Schrier Earlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complications Am J Kidney Dis 46 2005 415 423
12. R.W. Schrier Renal volume, renin-angiotensin-aldosterone system, hypertension and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease J Am Soc Nephrol 20 2009 1888 1893
13. R.W. Schrier, K. McFann, and A. Johnson Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease Kidney Int 63 2003 678 685
14. G.M. Fick, A.M. Johnson, W.S. Hammond, and P.A. Gabow Causes of death in autosomal dominant polycystic kidney disease J Am Soc Nephrol 5 1995 2048 2056
15. B. Orskov, V. Rømming Sørensen, B. Feldt-Rasmussen, and S. Strandgaard Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark Clin J Am Soc Nephrol 5 2010 2034 2039
16. C. Patch, J. Charlton, P.J. Roderick, and M.C. Gulliford Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study Am J Kidney Dis 57 2011 856 862